Skip to content

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101400
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Gastric cancer patients undergoing primary surgical treatment:No intervention
Gastric cancer patients undergoing surgery following neoadjuvant therapy:No intervention

Sponsors

Xijing Hospital, Air Force Medical University (PLA)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age at initial diagnosis: 18-75 years; 2) Histologically confirmed gastric or gastroesophageal junction malignancy, with complete medical records, confirmed pathological diagnosis, and definitive staging data (TNM staging system); 3) No history of other primary malignancies; 4) Absence of distant metastases (liver, lung, or other sites) confirmed by imaging examination (CT/MRI); 5) No prior surgical resection, chemotherapy, or PD-1/PD-L1 immunotherapy before enrollment; 6) Availability of complete biospecimen information, including: Sample ID (medical record number), Demographic data (sex, age), Clinical diagnostic data, Tumor marker profiles (CEA, CA19-9, etc.)

Exclusion criteria

Exclusion criteria: 1) Life expectancy <6 months (as assessed by ECOG score =4 or Palliative Performance Scale =30%), 2) Cognitive/psychiatric conditions: a. Legally incapacitated individuals without legal guardians, b. Active psychotic disorders (e.g., schizophrenia, bipolar disorder) or dementia (MMSE score <24), 3) Investigator-determined exclusions

Design outcomes

Primary

MeasureTime frame
Multi-gene methylation levels;

Secondary

MeasureTime frame
Tumor Markers;Imaging Examinations;

Countries

China

Contacts

Public ContactNie Yongzhan

Xijing Hospital, Air Force Medical University (PLA)

yongznie@fmmu.edu.cn+86 150 9152 0001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026